When is pulmonary hypertension not pulmonary hypertension?

K. Amshar, I. Armstrong, W. Wallice, T. W. Higenbottam, R. A. Lawson (Sheffield, United Kingdom)

Source: Annual Congress 2001 - Disease of the pulmonary circulation
Session: Disease of the pulmonary circulation
Session type: Oral Presentation
Number: 3515
Disease area: Interstitial lung diseases, Pulmonary vascular diseases

Congress or journal article abstract

Abstract

An echocardiographic finding of an elevated pulmonary artery pressure leads to most referrals for assessment at our pulmonary hypertension clinic. We report three cases referred primarily because of lung biopsies consistent with pulmonary hypertension, who were subsequently shown to have normal pulmonary artery pressures.
CASE 1:
A 50 year old female presented with a two year history of breathlessness and chest pain. Coronary angiography was normal. Echocardiographic pulmonary artery pressure was 28 mm Hg. Slight impairment of gas transfer led to a lung biopsy, which showed changes of pulmonary hypertension.
CASE 2:
A 61 year old male presented with a two year history of dyspnoea. Echocardiographic pulmonary artery pressure was 35 mm Hg. Although a CT scan showed minimal fibrosis, lung function tests showed marked reduction of gas transfer. A lung biopsy suggested pulmonary hypertension.
CASE 3:
A 51 year old female with lupus and positive anticardio-lipin antibodies presented with a two years of breathlessness. A thoracic CT showed mild nodularity. Her gas transfer was slightly decreased. A lung biopsy suggested pulmonary hypertension.
Each patient's right heart cathether was normal. In cases 1 and 3, despite extensive investigation, the patients's symptoms remain unexplained. In case 2, the unexplained low gas transfer accounts for the symptoms, but this in itself remains unaccounted for. We speculate the histological changes may result from previous small emboli or possibly even previous vaculitis, but investigations have been unable to support these suggestions. Without a specific diagnosis, treatment remains symptomatic. The patients are undergoing close review.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Amshar, I. Armstrong, W. Wallice, T. W. Higenbottam, R. A. Lawson (Sheffield, United Kingdom). When is pulmonary hypertension not pulmonary hypertension?. Eur Respir J 2001; 16: Suppl. 31, 3515

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010

Sarcoidosis-associated pulmonary hypertension
Source: Eur Respir Monogr 2022; 96: 234-255
Year: 2022


Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003



Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010



Pulmonary hypertension in children
Source: Eur Respir Mon 2012; 57: 94-107
Year: 2012


Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children
Source: Eur Respir J 2011; 37: 70-77
Year: 2011



Chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 637-648
Year: 2004



Pulmonary hypertension and pulmonary arterial hypertension: a clarification is needed
Source: Eur Respir J 2010; 36: 986-990
Year: 2010


COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Source: ERJ Open Res, 6 (4) 00520-2020; 10.1183/23120541.00520-2020
Year: 2020



ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021


Pulmonary hypertension: pathophysiology and diagnosis
Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment
Year: 2007



Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019



Pulmonary hypertension in sickle cell disease
Source: Annual Congress 2007 - ACCP1 - Pulmonary hypertension in sickle cell disease
Year: 2007

Portopulmonary hypertension
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=129
Year: 2005

Comparison of prevalence of diabetes mellitus in patients with idiopathic pulmonary arterial hypertension and distal chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013


The diagnosis of pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020

Diagnosing pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension
Year: 2015



Chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Update on venous thromboembolism
Year: 2007


Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010